Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pain education classes could ease fibromyalgia symptoms in rural patients

NCT ID NCT07280273

Symptom relief Sponsor: María Catalina Osuna Pérez Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether two 90-minute pain science education sessions can help 54 adults with fibromyalgia living in rural Spain. The sessions aim to change how patients think about pain, using simple language and metaphors. Researchers will measure pain sensitivity, daily function, and emotional well-being before, right after, and three months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pain Science Education (educational sessions)
What this could lead to
If it works, this could offer a simple, drug-free way to help people with fibromyalgia feel less pain and improve daily life.
What could go wrong
This is a small, early-stage trial with only 54 participants. The benefits may be modest or not last long, and results may not apply to everyone with fibromyalgia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 54 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of FM that meets the 2016 American College of Rheumatology (ACR) diagnostic criteria. * Residence in a rural area of the province of Jaén (Spain). * Age between 18 and 65 years. * Spanish reading ability. * Understanding and acceptance of the informed consent form to participate in the study. Exclusion Criteria: * -Patients diagnosed with any mental illness that prevents adherence to the intervention. * Patients diagnosed with inflammatory rheumatic disease. * Having a scheduled surgical intervention during the data collection process that could interfere with the results. * Being pregnant or breastfeeding. * Modification of pharmacological treatment during the study or in the last three months before the intervention. These criteria have been established from a review of other clinical trials conducted with similar interventions in patients with FMS.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibromyalgia syndrome

Contacts and locations

Locations

  • Fisio Mas, Peal de Becerro

    Jaén, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.